Terms: = Bone cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Diagnosis
205 results:
1. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
Troussard X; Maître E; Paillassa J
Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
[TBL] [Abstract] [Full Text] [Related]
2. Chronic lymphocytic leukaemia Australasian consensus practice statement.
Anderson MA; Bennett R; Badoux X; Best G; Chia N; Cochrane T; Cull G; Crassini K; Harrup R; Jackson S; Kuss B; Lasica M; Lew TE; Marlton P; Opat S; Palfreyman E; Polizzotto MN; Ratnasingam S; Seymour JF; Soosapilla A; Talaulikar D; Tam CS; Weinkove R; Wight J; Mulligan SP
Intern Med J; 2023 Sep; 53(9):1678-1691. PubMed ID: 37743239
[TBL] [Abstract] [Full Text] [Related]
3. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
[TBL] [Abstract] [Full Text] [Related]
4. From the archives of MD Anderson cancer Center: Sporadic Burkitt lymphoma with a complex karyotype and SOX11 expression.
Siddiqui SH; Thakral B; Aakash F; Ok CY; Tang Z; Medeiros LJ
Ann Diagn Pathol; 2023 Oct; 66():152182. PubMed ID: 37543028
[TBL] [Abstract] [Full Text] [Related]
5. Random Skin Biopsy for diagnosis of Intravascular Large B-Cell Lymphoma: A Case Report and Literature Review.
Lv Y; Xu L; Liu X; Wang Y
Am J Dermatopathol; 2023 May; 45(5):320-322. PubMed ID: 36939136
[TBL] [Abstract] [Full Text] [Related]
6. Metformin attenuates symptoms of osteoarthritis: role of genetic diversity of bcl2 and CXCL16 in OA.
Alimoradi N; Tahami M; Firouzabadi N; Haem E; Ramezani A
Arthritis Res Ther; 2023 Mar; 25(1):35. PubMed ID: 36879307
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical Characteristics and Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm].
Zhang XL; Liu B; Li N; Li LK; Ji XJ; Zhou XF; Wang MF; Xu HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):254-260. PubMed ID: 36765508
[TBL] [Abstract] [Full Text] [Related]
8. Follicular lymphoma: 2023 update on diagnosis and management.
Jacobsen E
Am J Hematol; 2022 Dec; 97(12):1638-1651. PubMed ID: 36255040
[TBL] [Abstract] [Full Text] [Related]
9. [Waldenström disease: News and perspectives in 2022].
Bouclet F; Krzisch D; Leblond V; Tomowiak C; Laribi K; Ysebaert L; Tournilhac O; Dartigeas C; Leprêtre S; Jondreville L;
Bull Cancer; 2023 Jan; 110(1):88-100. PubMed ID: 36229266
[TBL] [Abstract] [Full Text] [Related]
10. Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial.
Papachristofilou A; Bedke J; Hayoz S; Schratzenstaller U; Pless M; Hentrich M; Krege S; Lorch A; Aebersold DM; Putora PM; Berthold DR; Zihler D; Zengerling F; Dieing A; Mueller AC; Schaer C; Biaggi C; Gillessen S; Cathomas R
Lancet Oncol; 2022 Nov; 23(11):1441-1450. PubMed ID: 36228644
[TBL] [Abstract] [Full Text] [Related]
11. Pneumocystis jirovecii pneumonia [PJP]: An unrecognized concern in AML patients on Venetoclax.
Rainchwar S; Halder R; Singh R; Mehta P; Verma M; Agrawal N; Ahmed R; Bhurani D; Bansal N
Leuk Res; 2022 Oct; 121():106926. PubMed ID: 35994889
[TBL] [Abstract] [Full Text] [Related]
12. Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification.
Kriachok I; Stepanishyna Y; Skrypets T; Shokun N; Martynchyk A; Tytorenko I; Aleksik O; Krotevych M; Manni M; Federico M
Hematol Oncol; 2023 Feb; 41(1):196-200. PubMed ID: 35932211
[TBL] [Abstract] [Full Text] [Related]
13. Relationship between Bax and bcl-2 Protein Expression and Outcome of Induction Phase Chemotherapy in Pediatric Acute Lymphoblastic Leukemia.
Cahyadi A; Ugrasena IDG; Andarsini MR; Larasati MCS; Aryati A; Arumsari DK
Asian Pac J Cancer Prev; 2022 May; 23(5):1679-1685. PubMed ID: 35633553
[TBL] [Abstract] [Full Text] [Related]
14. Outcomes following venetoclax-based treatment in therapy-related myeloid neoplasms.
Shah MV; Chhetri R; Dholakia R; Kok CH; Gangat N; Alkhateeb HB; Al-Kali A; Patnaik MM; Baranwal A; Greipp PT; He R; Begna KH; Tiong IS; Wei AH; Hiwase D
Am J Hematol; 2022 Aug; 97(8):1013-1022. PubMed ID: 35560061
[TBL] [Abstract] [Full Text] [Related]
15. Clinical presentation, outcome, and prognostic markers in patients with intravascular large B-cell lymphoma, a lymphoma study association (LYSA) retrospective study.
Bonnet A; Bossard C; Gabellier L; Rohmer J; Laghmari O; Parrens M; Sarkozy C; Dulery R; Roland V; Llamas-Gutierrez F; Oberic L; Fornecker LM; Bounaix L; Villemagne B; Szablewski V; Choquet S; Bouabdallah K; Traverse-Glehen A; Mohty M; Sanhes L; Houot R; Gastinne T; Leux C; Le Gouill S
Cancer Med; 2022 Oct; 11(19):3602-3611. PubMed ID: 35538643
[TBL] [Abstract] [Full Text] [Related]
16. Models for Predicting Early Death in Patients With Stage IV Esophageal cancer: A Surveillance, Epidemiology, and End Results-Based Cohort Study.
Shi M; Zhai GQ
Cancer Control; 2022; 29():10732748211072976. PubMed ID: 35037487
[TBL] [Abstract] [Full Text] [Related]
17. Low bone Mineral Density and Calcium Levels as Risks for Mortality in Patients with Self-Discontinuation of Anti-Osteoporosis Medication.
Hsu CS; Chang ST; Cheng YY; Lee HT; Chen CH; Deng YL; Hsu CY; Chen YM
Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010457
[TBL] [Abstract] [Full Text] [Related]
18. Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge.
Khanlari M; Medeiros LJ; Lin P; Xu J; You MJ; Tang G; Yin CC; Wang W; Qiu L; Miranda RN; Bueso-Ramos CE; Li S
Mod Pathol; 2022 Mar; 35(3):419-426. PubMed ID: 34608246
[TBL] [Abstract] [Full Text] [Related]
19. [Endocrine late-effects and bone mineral density after combined treatment of malignant brain tumors in childhood and adolescence].
Golounina OO; Pavlova MG; Belaya ZE; Kim EI; Glinkina IV; Morgunova TB; Mazerkina NA; Zheludkova OG; Fadeev VV
Probl Endokrinol (Mosk); 2021 Jan; 67(1):31-40. PubMed ID: 33586390
[TBL] [Abstract] [Full Text] [Related]
20. bone marrow infiltrated natural killer cells predicted the anti-leukemia activity of MCL1 or bcl2 inhibitors in acute myeloid leukemia.
Dai YJ; He SY; Hu F; Li XP; Zhang JM; Chen SL; Zhang WN; Sun HM; Wang DW
Mol Cancer; 2021 Jan; 20(1):8. PubMed ID: 33402171
[TBL] [Abstract] [Full Text] [Related]
[Next]
